Rapid infectious disease test FI-CIC-525

fluCOVID-19for quality control

SCREEN IFA TEST COVID+INFLUENZA Product Code: FI-CIC-525 A Fluorescence Immunoassay test for qualitative detection of SARS-CoV-2 Nucleocapsid protein antigens, Influenza A and Influenza B virus in human nasopharynx with the use of SCREEN IFA ANALYZER. The COVID-19 Antigen/Influenza A+B Combo Test Cassette (Nasopharyngeal Swab) is intended for in vitro detection of SARS-CoV-2 Nucleocapsid protein, influenza A and B virus in nasopharyngeal swab specimens. It is intended to aid in the differential diagnosis of SARS-CoV-2, influenza A and B viral infections. The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract.